DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fludarabine
Fludarabine
Fludarabine Phosphate Powder for Solution for Injection Or Infusion
Fludarabine Phosphate (NSC 312878) Infusions for the Treatment of Acute Leukemia: Phase I and Neuropathological Study1
Fludarabine-Based Versus Chop-Like Regimens with Or Without Rituximab in Patients with Previously Untreated Indolent Lymphoma
©Ferrata Storti Foundation
Immune Recovery After Fludarabine–Cyclophosphamide
Prodrugs: a Challenge for the Drug Development
Sorafenib and Omacetaxine Mepesuccinate As a Safe and Effective Treatment for Acute Myeloid Leukemia Carrying Internal Tandem Du
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen
Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: an Observational Study
Package Leaflet: Information for the User Fludarabine Phosphate 25 Mg/Ml Concentrate for Solution for Injection Or Infusion Fludarabine Phosphate
Immunomodulatory Effects of Bendamustine in Hematopoietic Cell Transplantation
Powerpoint Sunusu
Cyclophosphamide-Fludarabine IV (3 Day) Ver
Acute Myeloid Leukemia (AML) Treatment Regimens
Chronic Myelogenous Leukemia (CML) Agents – Unified Formulary
Cancer Drug Costs for a Month of Treatment at Initial Food
Population Pharmacokinetics of Fludarabine in Patients with Aplastic Anemia and Fanconi Anemia Undergoing Allogeneic Hematopoiet
Top View
Fludarabine, High-Dose Cytarabine and Idarubicin-Based
Acronyms for Oncology Regimens
All-Trans Retinoic Acid and Arsenic Trioxide Resistance of Acute Promyelocytic Leukemia with the Variant STAT5B-RARA Fusion Gene
LYFCR Protocol
Fludarabine Plus Cyclophosphamide Combination: a New Standard for First-Line Therapy in Chronic Lymphocytic Leukaemia
Chemotherapy Drugs
Modifying Chemotherapy for the Older Patient
Subcutaneous Administration of Anticancer Agents
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
Prognostic Impact of Combined Fludarabine, Treosulfan and Mitoxantrone Resistance Profile in Childhood Acute Myeloid Leukemia
The Inhibitor of Histone Deacetylases Sodium Butyrate Enhances the Cytotoxicity of Mitomycin C
Fludarabine As First Line Therapy for Chronic Lymphocytic Leukaemia
Emetogenic Potential of Antineoplastic Agents
(PDF) Download
NCCN Guidelines for Acute Myeloid Leukemia from the 1.2014 Version Include
Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway Via
Adult Antiemetic Management of Chemotherapy-Induced Nausea
The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity Yishan Ye